Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.

Antimicrob Agents Chemother · 2020 · PMC7179297 · PMID 32041711

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

Although the difference between early and late recrudescence groups was not significant ( P = 0.06), the comparison was based on very small sample sizes ( n = 3 and n = 2), so the P value of borderline significance should not be interpreted as no difference in recrudescence time.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.